U.S. Retail Distributors Stock News

ATRenew (RERE) is back in focus after AI driven models downgraded the stock, citing negative operating cash flow, compressed gross margins, weak technical signals, and a valuation that appears elevated relative to current profitability. See our latest analysis for ATRenew. Despite the downgrade, ATRenew’s recent 1 day share price return of 5.38% to US$4.70 and 7 day share price return of 5.15% sit against a weaker 30 and 90 day share price trend. At the same time, the 1 year total shareholder...

In the past few days, ICL Group reported stronger-than-expected first-quarter 2024 results, with its specialty minerals segment outperforming and broader fertilizer markets showing signs of potash and phosphate price stabilization. This combination of operational outperformance and easing commodity price pressure has reinforced investor confidence in the company’s recovery prospects amid ongoing geopolitical supply concerns. We’ll now examine how this earnings beat, particularly in specialty...

Cimpress plc recently announced a share repurchase program authorizing the company to buy back up to US$200 million of its own stock. This sizeable authorization highlights management’s willingness to deploy capital toward reducing the share count, which can influence future earnings per share calculations. Next, we’ll explore how this US$200 million buyback plan might reshape Cimpress’ investment narrative and capital allocation outlook. AI is about to change healthcare. These 34 stocks are...

Bentley Systems (BSY) is back on many watchlists after a sector wide sell off tied to fears about AI driven seat compression, where automation could shrink paid user counts for enterprise software subscriptions. See our latest analysis for Bentley Systems. The recent sector sell off has pushed Bentley Systems’ 1 month share price return to a 14.06% decline and its 1 year total shareholder return to a 22.52% loss, suggesting that sentiment and momentum have been fading, even with the latest...

Earlier in April 2026, McEwen Inc. reported an updated Mineral Resource Estimate for its Tartan Mine Project in Manitoba, outlining 308,900 Indicated and 302,700 Inferred gold ounces and initial annual production plans of about 30,000 ounces. This update feeds into McEwen’s broader goal of lifting overall gold output by 2030, potentially reshaping how investors view the company’s long-term production profile and asset base. We’ll now examine how the updated Tartan Mine resource and its...

The Centers for Medicare & Medicaid Services recently approved a 2.48% payment increase for 2027 Medicare Advantage plans, plus an additional uplift from risk-scoring changes, effectively raising government reimbursement for insurers like Alignment Healthcare. This higher-than-expected rate setting meaningfully improves the economics of Medicare Advantage plans, potentially enhancing Alignment Healthcare’s ability to fund benefits, invest in care programs, and absorb medical cost...

ICU Medical, Inc. recently held its 2026 Annual Meeting of Stockholders, where investors voted on amendments to adopt simple majority voting and to allow shareholders owning at least 25% of the company’s voting power to call special meetings, contingent on related bylaw changes becoming effective after filing in Delaware. At the same time, the board urged investors to oppose a separate shareholder proposal to lower the special-meeting ownership threshold to 10%, highlighting an active debate...

Morningstar, Inc. previously announced an expanded availability of its investment datasets on Snowflake Marketplace, allowing institutional investors to access Morningstar Licensed Data, Indexes, Sustainalytics, DBRS, and Credit Analytics directly within Snowflake’s secure AI Data Cloud. This broadened distribution means clients can work with equity, ESG, index, and credit datasets inside a single cloud-native environment, potentially simplifying integration and scaling of research and risk...

Why the Unrivaled Sports partnership matters for Under Armour stock Under Armour (UAA) is back in focus after Unrivaled Sports announced new partnerships with the brand and DICK'S Sporting Goods, positioning Under Armour as the exclusive performance apparel partner across several youth tournaments. See our latest analysis for Under Armour. At a share price of US$6.14, Under Armour has seen a 4.1% 7 day share price return and a 16.1% year to date share price return. The 5 year total...

Regulatory risk moves into focus for Edison International stock California lawmakers are advancing a measure to require independent audits of utility wildfire mitigation spending, putting Edison International (EIX) and its wildfire-related costs under closer scrutiny at a time of rising regulatory attention. See our latest analysis for Edison International. The stock pulled back 4.4% on the day to US$72.39, yet its 19.3% 3 month share price return and 34.0% 1 year total shareholder return...

Why Borr Drilling (NYSE:BORR) Is On Investors’ Radar Today Borr Drilling (NYSE:BORR) has drawn attention after a stretch of strong recent share price performance. This includes a 17.8% move over the past month and 36.1% over the past 3 months, prompting closer inspection of its fundamentals. See our latest analysis for Borr Drilling. The recent 17.8% 1 month share price return and 36.1% 3 month share price return come on top of a 49.4% year to date share price return and a very large 1 year...

In early April 2026, PowerBridge LLC announced it had entered into a lease development agreement with LandBridge Company LLC, securing the option to lease up to 3,400 acres in Reeves County, Texas for a giga-scale data center campus with as much as 2 GW of initial co-located power generation and associated private power infrastructure under development. This potential “Alpha Digital Campus” adds a large-scale digital infrastructure and power project to LandBridge’s Permian footprint,...

In early April 2026, Alkermes plc announced that it had initiated the Brilliance phase 3 program to evaluate its oral orexin 2 receptor agonist alixorexton in adults with narcolepsy type 1 and type 2 across three 12-week, randomized, double-blind, placebo-controlled studies. The launch of these global Brilliance Studies marks a significant step in advancing orexin-targeted therapies, potentially broadening Alkermes’ footprint in sleep-wake disorders if outcomes are favorable. With phase 3...

Earlier in April, MYR Group, an electrical construction and infrastructure services provider, saw its outlook improve after a U.S.–Iran ceasefire agreement tied to reopening the Strait of Hormuz eased concerns around fuel and logistics disruptions. This geopolitical thaw may encourage commercial and utility clients to move ahead with previously delayed maintenance and infrastructure projects, potentially supporting MYR Group’s project pipeline and backlog quality. With tensions easing and...

Considering whether Northrop Grumman at around US$681 per share is offering fair value or asking you to pay up for quality is a useful starting question before committing fresh capital. The stock has pulled back 2.1% over the last 7 days and 7.1% over the last 30 days, while still showing returns of 16.3% year to date and 29.2% over the last year. Recent coverage has highlighted Northrop Grumman as a key name in defense and aerospace, with attention on its role in long term government and...

Chipotle’s new rewards push and what it might mean for CMG stock Chipotle Mexican Grill (CMG) has rolled out its upgraded Rewards on Repeat program and refreshed app across the US and Canada, putting customer loyalty and digital engagement in sharper focus for investors watching the stock. See our latest analysis for Chipotle Mexican Grill. Recent trading points to a rebound in momentum, with a 1 month share price return of 6.37% and a 7 day share price gain of 3.25%. However, the 1 year...

With energy shocks, higher inflation risks, and rising global bond yields keeping markets on edge, many investors are looking beyond traditional growth stories and searching for themes that could reshape entire sectors over time. One of the clearest examples is artificial intelligence in healthcare, where AI tools are being used to improve diagnostics, personalise treatments, cut hospital bottlenecks, support remote care, and speed up drug discovery. This article highlights 3 stocks from the...

If you are wondering whether Berkshire Hathaway's current share price offers value or just reflects past success, it helps to step back and look at what the market is really pricing in. The stock last closed at US$720,750, with returns of 0.6% over 7 days, a 1.9% decline over 30 days, a 3.1% decline year to date, a 9.2% decline over 1 year, 44.8% over 3 years and 77.3% over 5 years, which gives a mixed picture for anyone thinking about risk and opportunity. Recent coverage has focused on...

The Cheesecake Factory recently rolled out a new mobile app tied to its Cheesecake Rewards program, offering members a free slice of any cheesecake or layer cake with any purchase for downloads and logins completed between April 1 and April 30, 2026. By marrying a generous, time-limited giveaway with its nationwide loyalty platform, the company is using digital engagement to deepen customer relationships and potentially increase visit frequency. Next, we’ll examine how this push into...

Graco (NYSE:GGG) director Brett C. Carter has resigned from the Board of Directors, affecting the company’s board composition and governance. The company has granted multi year stock option awards to CEO Mark W. Sheahan and EVP Laura L. Evanson, which aligns leadership incentives with longer term equity performance. These developments relate to board structure and executive compensation, areas that many investors track as material to oversight and leadership stability. Graco, a manufacturer...

In April 2026, Snappt and CLEAR announced a case study showing how integrating CLEAR1 into Snappt’s Applicant Trust Platform helped multifamily housing owners and operators verify identities alongside financial checks, flagging more than 5,400 fraudulent rental applications and preventing over US$10 million in potential bad debt within six months. This collaboration underscores CLEAR’s push to extend its identity technology beyond airports into fraud-heavy verticals like multifamily housing,...

Foresight Financial Group (FGFH) has just posted Q4 2025 numbers that cap off a softer year, with total revenue of US$3.3 million, basic EPS of US$0.70 and trailing twelve month revenue of US$46.5 million translating into EPS of US$2.18. Over the past year, total revenue on a trailing basis moved from US$49.5 million in Q4 2024 to US$46.5 million in Q4 2025 while trailing EPS went from US$3.61 to US$2.18, setting the scene for a story where margins and earnings quality sit firmly in...

Framing CRISPR Therapeutics After Recent Performance CRISPR Therapeutics (CRSP) has recently drawn attention after a 7.0% one day gain, adding to a 12.5% move over the past month, while its past 3 months return sits modestly negative. See our latest analysis for CRISPR Therapeutics. At a share price of $54.83, the recent 1 day and 1 month share price returns sit against a modestly positive year to date move. The 1 year total shareholder return of 41.28% contrasts sharply with a 5 year total...

AtaiBeckley Inc. recently reported peer-reviewed Phase 2a results in CNS Drugs showing that a single intranasal dose of BPL-003, alongside stable SSRI therapy, produced rapid and sustained reductions in MADRS scores in 12 adults with treatment-resistant depression without serious adverse events and with discharge readiness at around 100 minutes post-dose. An important angle for investors is that these data, together with prior monotherapy findings, supported successful End-of-Phase 2...